Source: PR Newswire — Lab-Grown Neurons "Hello World" and Intactis Bio $250K Raise

source confidence: Medium status: Useful updated 2026-06-19

Type
source
Status
Useful
Confidence
Medium
Source Type
press-release
URL
https://www.prnewswire.com/news-releases/lab-grown-neurons-say-hello-world-and-perform-matrix-math-on-automated-platform-intactis-bio-corp-raises-250k-from-nucleus-fund-302724652.html
Archive
https://web.archive.org/web/20260724120713/https://www.prnewswire.com/news-releases/lab-grown-neurons-say-hello-world-and-perform-matrix-math-on-automated-platform-intactis-bio-corp-raises-250k-from-nucleus-fund-302724652.html
Archived
2026-07-24
Publisher
PR Newswire / Intactis Bio Corp
Raw
raw/intactis-bio-prnewswire/2026-08-11-d09e40e73260.txt
Retrieved
2026-08-12
Updated
2026-06-19

Summary

Company-issued press release announcing that Intactis Bio Corp raised $250K from Nucleus Fund and demonstrated iPSC-derived neurons performing task-distinct activity patterns for arithmetic and language inputs on their automated biocomputation platform.

Useful Claims

  • Intactis Bio Corp raised $250,000 from Nucleus Fund (pre-seed).
  • The company demonstrated lab-grown neurons producing task-distinct activity patterns for arithmetic and language inputs — the "Hello, World" milestone.
  • The platform automates biochip workflows allowing customers to run AI/ML workloads against living-neuron biochips with silicon baselines.
  • Intactis is a resident at Altitude Lab in Salt Lake City and spun out of University of Utah research.

Verbatim

"Intactis Bio Corp, a leader in biohybrid computing, announced a major milestone: in a controlled laboratory setting, living brain cells (neurons) successfully performed math operations and transmitted the phrase "Hello, World!"" — Press release, lead paragraph

"In this recent demonstration, the team grew neurons from induced pluripotent stem cells (iPSCs), which are commercially available cells that can be turned into many different cell types." — Press release, body

"At the same time, Nucleus Fund invested $250,000 in Intactis Bio Corp to help the company grow its platform, increase the difficulty of the tasks it can handle, and move toward commercialization." — Press release, body

"This work was also supported by a SHIFT grant ( shiftgrants.org ) and a Trail Angel Grant from Altitude Lab ( https://www.altitudelab.org/financial-awards )." — Press release, body

Reliability Notes

Primary source for the funding amount and lab demonstration claim, but company-issued — all technical performance claims are self-reported and have not been independently peer-reviewed. The funding figure ($250K from Nucleus Fund) is corroborated by the Nucleus Fund website.

Related Pages